Acetyltransferases (HATs) as targets for neurological therapeutics - Test2 - elhamkhani - TriplyDB

Acetyltransferases (HATs) as targets for neurological therapeutics

Acetyltransferases (HATs) as targets for neurological therapeutics

http://www.wikidata.org/entity/Q37249167

about

Epigenetic Mechanisms in Developmental Alcohol-Induced Neurobehavioral Deficits Behavioral Neuroadaptation to Alcohol: From Glucocorticoids to Histone Acetylation Epigenetic memory: the Lamarckian brain K-Lysine acetyltransferase 2a regulates a hippocampal gene expression network linked to memory formation Synaptic therapy in Alzheimer's disease: a CREB-centric approach.Histone acetylation inhibitors promote axon growth in adult dorsal root ganglia neurons Tip off the HAT- Epigenetic control of learning and memory by Drosophila Tip60 The epigenetics of stroke recovery and rehabilitation: from polycomb to histone deacetylases.Histone-acetylation: a link between Alzheimer's disease and post-traumatic stress disorder?Alterations in Histone Acetylases and Acetylated Histone Expression in Aging, Ethanol-Fed Rats.Epigenetics and addiction.A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.A hybrid of thiazolidinone with the hydroxamate scaffold for developing novel histone deacetylase inhibitors with antitumor activities.Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.Looking above but not beyond the genome for therapeutics in neurology and psychiatry: epigenetic proteins and RNAs find a new focus.Histone Acetylation Regulation in Sleep Deprivation-Induced Spatial Memory Impairment.[Epigenetic regulations and cerebral plasticity: towards new therapeutic options in neurodegenerative diseases?]Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator

P2860

Q26748876-1E18F6FA-3C38-410A-A46A-57E2F6F9123B Q28073838-1527BA9D-21C5-49DF-AA06-59814494871F Q34323841-F4D38CA5-08BA-4FD3-B0F9-09ECECFD3BB7 Q34332494-AE52349D-3A01-4692-BA50-FC2E15C392EE Q35064948-C6606E53-CE22-4C04-BF4F-22B19FC3CA31 Q35853603-ECF3B5CC-6908-4A43-B137-9129FB6CC132 Q36124880-255A31E1-963C-4A2A-B9F9-03D035E1F01C Q38149089-0AE4CE84-AFF0-4058-B90B-DB90BDA77C52 Q38227853-8C0850E4-7FEB-4517-AF29-D9CC9B3E59E0 Q38601775-5B105482-E9A0-4BA3-82C2-A388999593A5 Q38721724-F7DE22C5-1814-444B-857D-9046AC3CE44A Q38766912-7C92AD06-92E2-4522-B984-6AF20D838692 Q38806404-1486D2B8-5CC3-476B-A0B1-2FEA28E1977E Q42776375-C1E59317-A991-4D0A-8CDC-927A4229CE9C Q42937645-8DF5F096-C4E3-4B14-83D6-6984DDF4CE3A Q47859053-77555527-E71A-4860-9BA7-0138577BEC3E Q50542122-A41DB082-BC14-4E86-B134-BA148A795C29 Q57054631-5F73058F-1F12-4946-A8BE-62AE1BAEE380

P2860

Acetyltransferases (HATs) as targets for neurological therapeutics

http://www.wikidata.org/entity/Q37249167

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Acetyltransferases (HATs) as targets for neurological therapeutics

@en

Acetyltransferases

@nl

type

label

Acetyltransferases (HATs) as targets for neurological therapeutics

@en

Acetyltransferases

@nl

prefLabel

Acetyltransferases (HATs) as targets for neurological therapeutics

@en

Acetyltransferases

@nl

P1433

Q37249167-CDDBC778-53EA-42B3-9678-D0A2348775AA

P1476

Q37249167-98491289-A28C-400F-80A4-AF316E62C974

P2093

Q37249167-42EE7705-9B63-4CA0-BEAC-44F326DB91FD

Q37249167-46B7A26F-1104-43DF-A9AB-F9ABFD326EED

Q37249167-74D65664-7026-4FD6-9643-1FA1C035F376

Q37249167-B56B426E-EA71-4B7D-B596-F11960922071

Q37249167-C4F34672-8F9B-498D-8D74-64BEB24C3761

Q37249167-D07BA495-C4D5-4BEB-BC35-4F3639BD9A15

P2860

Q37249167-001C7A6B-06C2-4A15-B935-85E7C36A1A72

Q37249167-0025F5E8-E587-4958-BF01-07988D843A9E

Q37249167-01084A27-3E6A-4D00-B334-A752BD70B27A

Q37249167-0154B580-4353-4DF6-84F3-EBA854CDF5F6

Q37249167-01C29D30-6718-42FD-8069-6625C3542174

Q37249167-01E7B6D1-24F3-46AB-B4CE-466EE4710807

Q37249167-032C6BBA-C2FD-4DF1-90C8-19A72CD4B18F

Q37249167-057E3B85-45E6-4333-91CF-468D85B85AF5

Q37249167-05B9E542-109A-49EA-917F-101102598EDD

Q37249167-06185EEC-7AC9-4FC9-97A9-8B4D01AE90B2

P2888

Q37249167-44A95026-AA09-4934-AC59-C763CB3ABA18

P304

Q37249167-5FD16AC1-BECF-4764-ACDF-B92DD9892897

P31

Q37249167-C1482EE8-2B62-4285-9D7C-D1F2B0CC8D4A

P356

Q37249167-B452B514-F05B-487C-94CB-0A45C939B5B3

P433

Q37249167-3FD749FB-8BE6-4134-A47D-4698F73E80E7

P478

Q37249167-A06BCBF9-9324-461C-B1FF-A537375AC6C9

P50

Q37249167-04313DC7-27FC-4008-A714-BD2E46220D52

Q37249167-1F0DCCBC-DCD1-49E1-AD3F-33C2EA6662C1

Q37249167-56A6E86E-5D5B-49AD-B7C6-B9AA473B2F0A

P577

Q37249167-A9E2282B-FC2E-485D-AE37-0FB520D48242

P5875

Q37249167-FB11B2F3-27F2-4E27-AB17-C97DC8F8E155

P698

Q37249167-6B3F34C3-176F-4E67-BA6D-AFF1A826799D

P932

Q37249167-13CE194D-68DE-4DCB-851C-6E2BA93CF942

P356

S13311-013-0204-7

P1433

Neurotherapeutics

P1476

Acetyltransferases (HATs) as targets for neurological therapeutics

@en

P2093

Anne Schneider

http://www.w3.org/2001/XMLSchema#string

Anne-Laurence Boutillier

http://www.w3.org/2001/XMLSchema#string

B Ruthrotha Selvi

http://www.w3.org/2001/XMLSchema#string

Raphaelle Cassel

http://www.w3.org/2001/XMLSchema#string

Snehajyoti Chatterjee

http://www.w3.org/2001/XMLSchema#string

Tapas K Kundu

http://www.w3.org/2001/XMLSchema#string

P2860

Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60

Regulation of cellular metabolism by protein lysine acetylation

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin

HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation

Acetylation of histones and transcription-related factors

P2888

s13311-013-0204-7

P304

568-588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-013-0204-7

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Amrutha Swaminathan

Olivier Bousiges

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256449491

http://www.w3.org/2001/XMLSchema#string

P698

24006237

http://www.w3.org/2001/XMLSchema#string

P932

3805875

http://www.w3.org/2001/XMLSchema#string